Estimates from World Health Organization indicates that over 750 million people are living with obesity and the global market for anti-obesity medications in 2023 reached $6 billion
Last reviewed: June 16, 2026 Last updated: June 16, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
as well as pharmaceutical and medical device intellectual property including trademark, copyright, trade secret and all aspects of patent law (due diligence, prosecution, opinion work, litigation, and transactional matters)
Your WeightWatchers Clinic care team will also be able to help coach you through dose increases to help minimize the potential for side effects
Both Kaiser CA and Blue Shield of California applied the BMI-40 restriction for new weight-loss GLP-1 starts effective January 1, 2025
Click Here to embark on this journey towards practice enhancement today!